Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alessio Molfino, Maria Ida Amabile, Filippo Rossi Fanelli & Maurizio Muscaritoli. (2016) Novel therapeutic options for cachexia and sarcopenia. Expert Opinion on Biological Therapy 16:10, pages 1239-1244.
Read now
Read now
Lei Sun, Xiao-Qing Quan & Shiying Yu. (2015) An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status. Nutrition and Cancer 67:7, pages 1056-1062.
Read now
Read now
Clelia Madeddu, Giovanni Mantovani, Giulia Gramignano & Antonio Macciò. (2015) Advances in pharmacologic strategies for cancer cachexia. Expert Opinion on Pharmacotherapy 16:14, pages 2163-2177.
Read now
Read now
S Bordonaro, F Romano, E Lanteri, F Cappuccio, R Indorato, A Butera, A D’Angelo, F Ferraù & P Tralongo. (2014) Effect of a structured, active, home-based cancer-treatment program for the management of patients on oral chemotherapy. Patient Preference and Adherence 8, pages 917-923.
Read now
Read now
Thoralf Christoffersen. (2013) Cancer, cachexia, prostanoids, and NSAIDs. Acta Oncologica 52:1, pages 3-5.
Read now
Read now
Articles from other publishers (29)
Anupam Rej & David S. Sanders. 2022. Yamada's Textbook of Gastroenterology. Yamada's Textbook of Gastroenterology
567
576
.
Yonghua Li, Huan Jin, Yibing Chen, Ting Huang, Yanjun Mi & Zhengzhi Zou. (2021) Cancer cachexia: molecular mechanism and pharmacological management. Biochemical Journal 478:9, pages 1663-1688.
Crossref
Crossref
Antonio Maccio, Elisabetta Sanna, Manuela Neri, Sara Oppi & Clelia Madeddu. (2021) Cachexia as Evidence of the Mechanisms of Resistance and Tolerance during the Evolution of Cancer Disease. International Journal of Molecular Sciences 22:6, pages 2890.
Crossref
Crossref
Antonio Macciò, Sara Oppi & Clelia Madeddu. (2021) COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?. Journal of Ovarian Research 14:1.
Crossref
Crossref
Iñaki Eguren-Santamaría, Carlos Centeno & Ignacio Gil-Bazo. 2021. Practical Medical Oncology Textbook. Practical Medical Oncology Textbook
327
347
.
Ling-ling Sun, He-zheng Lai, Zhuang-zhong Chen, Xiao-shu Zhu & Li-zhu Lin. (2020) Modified Liujunzi Decoction (六君子汤) Alleviates Chemotherapy-Induced Anorexia in Advanced Non-Small Cell Lung Cancer: A Propensity Score Matched Case-Control Study. Chinese Journal of Integrative Medicine 26:4, pages 256-262.
Crossref
Crossref
Megan E. Rosa-Caldwell, Dennis K. Fix, Tyrone A. Washington & Nicholas P. Greene. (2020) Muscle alterations in the development and progression of cancer-induced muscle atrophy: a review. Journal of Applied Physiology 128:1, pages 25-41.
Crossref
Crossref
Meera Agar & Valentina Razmovski-Naumovski. 2019. Textbook of Palliative Care. Textbook of Palliative Care
275
293
.
Kyohei Araki, Yasuyoshi Miyata, Kojiro Ohba, Yuichiro Nakamura, Tomohiro Matsuo, Yasushi Mochizuki & Hideki Sakai. (2018) Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines 6:1, pages 2.
Crossref
Crossref
Mohammadamin Sadeghi, Mahsa Keshavarz-Fathi, Vickie Baracos, Jann Arends, Maryam Mahmoudi & Nima Rezaei. (2018) Cancer cachexia: Diagnosis, assessment, and treatment. Critical Reviews in Oncology/Hematology 127, pages 91-104.
Crossref
Crossref
Meera Agar & Valentina Razmovski-Naumovski. 2018. Textbook of Palliative Care. Textbook of Palliative Care
1
20
.
Xueli Zhang, Yamin Liu, Hua Shao & Xiao Zheng. (2017) Obesity Paradox in Lung Cancer Prognosis: Evolving Biological Insights and Clinical Implications. Journal of Thoracic Oncology 12:10, pages 1478-1488.
Crossref
Crossref
David C Currow & Richard JE Skipworth. (2017) The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia. Future Oncology 13:20, pages 1767-1783.
Crossref
Crossref
Sanda Vladimir‐Knežević, Biljana Blažeković, Maja Bival Štefan & Marija Kindl. 2017. Natural Products and Cancer Drug Discovery. Natural Products and Cancer Drug Discovery.
Lindsey J. Anderson, Eliette D. Albrecht & Jose M. Garcia. (2017) Update on Management of Cancer-Related Cachexia. Current Oncology Reports 19:1.
Crossref
Crossref
Jianhua Su, Jin Geng, Jisheng Bao, Yin Tang, Menglan Liu, Haibin Yu, Yi Han, Wei Huang & Suming Zhou. (2016) Two ghrelin receptor agonists for adults with malnutrition: a systematic review and meta-analysis. Nutrition Journal 15:1.
Crossref
Crossref
Tara C. Mueller, Jeannine Bachmann, Olga Prokopchuk, Helmut Friess & Marc E. Martignoni. (2016) Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?. BMC Cancer 16:1.
Crossref
Crossref
Sriram Yennurajalingam, Janet L. Williams, Gary Chisholm & Eduardo Bruera. (2016) Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report. The Oncologist 21:3, pages 384-390.
Crossref
Crossref
Yu-Chou Tseng, Samuel K. Kulp, I-Lu Lai, En-Chi Hsu, Wei A. He, David E. Frankhouser, Pearlly S. Yan, Xiaokui Mo, Mark Bloomston, Gregory B. Lesinski, Guido Marcucci, Denis C. Guttridge, Tanios Bekaii-Saab & Ching-Shih Chen. (2015) Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia. Journal of the National Cancer Institute 107:12, pages djv274.
Crossref
Crossref
Leigh A. Cantrell, Erin Saks, Valentina Grajales & Linda Duska. (2015) Nutrition in Gynecologic Cancer. Current Obstetrics and Gynecology Reports 4:4, pages 265-271.
Crossref
Crossref
Sreedhar Subramanian & Jonathan M. Rhodes. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
666
675
.
Christine Baldwin. (2015) The effectiveness of nutritional interventions in malnutrition and cachexia. Proceedings of the Nutrition Society 74:4, pages 397-404.
Crossref
Crossref
Amelia J. Johnston, Kate T. Murphy, Laura Jenkinson, David Laine, Kerstin Emmrich, Pierre Faou, Ross Weston, Krishnath M. Jayatilleke, Jessie Schloegel, Gert Talbo, Joanne L. Casey, Vita Levina, W. Wei-Lynn Wong, Helen Dillon, Tushar Sahay, Joan Hoogenraad, Holly Anderton, Cathrine Hall, Pascal Schneider, Maria Tanzer, Michael Foley, Andrew M. Scott, Paul Gregorevic, Spring Yingchun Liu, Linda C. Burkly, Gordon S. Lynch, John Silke & Nicholas J. Hoogenraad. (2015) Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival. Cell 162:6, pages 1365-1378.
Crossref
Crossref
Philip T. Leese, John M. Trang, Robert A. Blum & Eleanor de Groot. (2015) An open‐label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin. Clinical Pharmacology in Drug Development 4:2, pages 112-120.
Crossref
Crossref
Yunfeng Wang, Xiujie Chen, Lei Liu, Yuelong Chen, Hongzhe Ma, Ruizhi Yang & Xiangqiong Liu. (2015) Identifying the causative proteins of similar side effect pairs to explore the common molecular basis of these side effects. Molecular BioSystems 11:7, pages 2060-2067.
Crossref
Crossref
Antonio Macciò, Giulia Gramignano & Clelia Madeddu. (2015) Surprising results of a supportive integrated therapy in myelofibrosis. Nutrition 31:1, pages 239-243.
Crossref
Crossref
José M Garcia, Ralph V Boccia, Charles D Graham, Ying Yan, Elizabeth Manning Duus, Suzan Allen & John Friend. (2015) Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. The Lancet Oncology 16:1, pages 108-116.
Crossref
Crossref
Maureen T. Lynch. (2014) Palliative Care at the End of Life. Seminars in Oncology Nursing 30:4, pages 268-279.
Crossref
Crossref
Rosamund C. Smith & Boris K. Lin. (2013) Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders. Current Opinion in Supportive & Palliative Care 7:4, pages 352-360.
Crossref
Crossref